Fresenius stock trades at EUR 45.96 in weekend trading

Published on 10/24/2026 at 10:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius stock is EUR 45.96 in weekend trading on October 24, 2026. That is 0.30 percent below the October 23 Xetra close of EUR 46.10.

Key corporate dates

Fresenius appointed Dr. Marc-Alexander Mahl to its Management Board on October 15, 2026, while extending Sara Hennicken’s contract through 2032.
Fresenius stock trades in weekend trading at EUR 45.96 at 10:05 a.m. CEST on October 24, 2026, 0.30 percent below the Xetra close of October 23, 2026.
The last Xetra close was EUR 46.10 on October 23, 2026.
Fresenius is scheduled to publish its third-quarter 2026 financial results on November 4, 2026.

Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht — Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

Fresenius stock trades at EUR 45.96 in weekend trading at Lang & Schwarz at 10:05 a.m. CEST on October 24, 2026, 0.30 percent below the Xetra close of October 23, 2026, at EUR 46.10.

Weekend trading

The quote was EUR 45.96 at Lang & Schwarz at 10:05 a.m. CEST on October 24, 2026. The Xetra reference was the closing price of EUR 46.10 on October 23, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Fresenius stock.

The week in figures

The latest Xetra close was EUR 46.10 on October 23, 2026. The weekend indication at Lang & Schwarz was EUR 45.96 on October 24, 2026, representing a 0.30 percent discount to that dated Xetra reference.

Chronology of the week

On October 15, 2026, the Supervisory Board appointed Dr. Marc-Alexander Mahl to the Fresenius Management Board effective November 1, 2026. It also extended Chief Financial Officer Sara Hennicken’s contract for another five years, through 2032. The company reported the decisions on its Investor Relations overview.

On October 13, 2026, Fresenius published its Q3 2026 Aide Memoire and stated that its third-quarter financial results would be released on November 4, 2026. The date appears in the company’s Investor Relations overview.

Dates of the coming week

The next Xetra session is dated October 26, 2026. Fresenius’ next substantiated company date is November 4, 2026, when the company plans to publish its third-quarter 2026 financial results, according to its Investor Relations overview.

Market context: Market report DAX.